<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Clinical Ophthalmology</journal-id><journal-title-group><journal-title>Clinical Ophthalmology (Auckland, N.Z.)</journal-title></journal-title-group><issn pub-type="ppub">1177-5467</issn><issn pub-type="epub">1177-5483</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20054415</article-id><article-id pub-id-type="pmc">2801636</article-id><article-id pub-id-type="publisher-id">opth-3-671</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Differences between the combination of the 25-gauge vitrectomy with phacoemulsification versus 20-gauge vitrectomy and phacofragmentation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Romero-Aroca</surname><given-names>Pere</given-names></name><xref ref-type="aff" rid="af1-opth-3-671">1</xref><xref ref-type="corresp" rid="c1-opth-3-671"/></contrib><contrib contrib-type="author"><name><surname>Almena-Garcia</surname><given-names>Matias</given-names></name><xref ref-type="aff" rid="af1-opth-3-671">1</xref></contrib><contrib contrib-type="author"><name><surname>Baget-Bernaldiz</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="af1-opth-3-671">1</xref></contrib><contrib contrib-type="author"><name><surname>Fern&#x000e1;ndez-Ballart</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="af2-opth-3-671">2</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000e9;ndez-Marin</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="af1-opth-3-671">1</xref></contrib><contrib contrib-type="author"><name><surname>Bautista-Perez</surname><given-names>Angel</given-names></name><xref ref-type="aff" rid="af1-opth-3-671">1</xref></contrib></contrib-group><aff id="af1-opth-3-671"><label>1</label>Ophthalmic Service, Hospital Universitario Sant Joan, IISPV, Universidad Rovira I Virgili, Reus, Spain;</aff><aff id="af2-opth-3-671"><label>2</label>Department of Basic Sciences, University Rovira I Virgili, Tarragona, Spain</aff><author-notes><corresp id="c1-opth-3-671">Correspondence: Pedro Romero, C/Ample 55 1&#x000b0; 43202, Reus (Tarragona), Spain, Tel 0034977310300, Ext 5308, Fax +34 9 7732 3754, Email 
<email>romeropere@gmail.com</email>, 
<email>promero@grupsagessa.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><!--Dove Press titles changed from ppub to collections in 2009.
								Fake ppub written to satisfy Coll Date Type=ppub--><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>29</day><month>12</month><year>2009</year></pub-date><volume>3</volume><fpage>671</fpage><lpage>679</lpage><history><date date-type="received"><day>16</day><month>11</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Romero-Aroca et al, publisher and licensee Dove Medical Press Ltd.</copyright-statement><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Introduction:</title><p>In the present study we determine the differences observed between 25-gauge-vitrectomy combined with phacoemulsification, and the 20-gauge-vitrectomy combined with pars plana phacofragmentation.</p></sec><sec><title>Methods:</title><p>A prospective study of a sample of 987 eyes of 661 patients randomly divided into two groups. 25-gauge-vitrectomy plus phacoemulsification included 486 eyes, and 20-gauge-vitrectomy plus phacofragmentation 501 eyes. We evaluated the differences at the time of the surgery, the intra-and postoperative complications, and the variations in intraocular pressure.</p></sec><sec><title>Results:</title><p>The final visual outcome was similar in both groups. The most important differences between groups were: surgical time was faster in group 1 than in group 2, (mean time: 35.16 &#x000b1; 3.49, 44.74 &#x000b1; 5.30 minutes). Intraoperative complications were more numerous in group 1. In group 1, postoperative low levels of intraocular pressure are present in all patients with 2.77% of patients with hypotension (&#x0003c;8 mmHg), and three choroidal effusion. In group 2, intraocular lens decentration and retinal detachment are more frequent (2.38% and 1.39%, respectively).</p></sec><sec><title>Conclusions:</title><p>In the present study, both techniques have a similar number of complications and have a similar postoperative outcome, and are valid for the management of the pathologies selected.</p></sec></abstract><kwd-group><kwd>transconjunctival sutureless vitrectomy</kwd><kwd>sutureless vitrectomy</kwd><kwd>25-gauge</kwd><kwd>20-gauge</kwd><kwd>cataract</kwd><kwd>phacoemulsification</kwd><kwd>phacofragmentation</kwd><kwd>hypotony</kwd><kwd>complications</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Vitrectomy has been used to treat vitreoretinal disorders for more than 25 years.<xref ref-type="bibr" rid="b1-opth-3-671">1</xref>,<xref ref-type="bibr" rid="b2-opth-3-671">2</xref> The management of the lens during vitrectomy has come full circle since the first vitrectomy interventions.<xref ref-type="bibr" rid="b3-opth-3-671">3</xref>,<xref ref-type="bibr" rid="b4-opth-3-671">4</xref> The lens is removed frequently during surgery even if clear, and the lens status affects the management of retinal pathologies by pars plana vitrectomy. In many cases, it is advantageous to remove the lens, such as in patients with proliferative diabetic retinopathy, which permits better dissection of the anterior vitreous.<xref ref-type="bibr" rid="b5-opth-3-671">5</xref></p><p>If the lens is not removed during the vitrectomy, one of the most likely outcomes is cataract formation. In young patients, a cataract may take many years to develop, but in older patients, especially those aged over 60 years, with pre-existing nuclear sclerosis, visual loss may develop from a cataract much sooner, forcing cataract extraction in a short time after vitrectomy.<xref ref-type="bibr" rid="b6-opth-3-671">6</xref>&#x02013;<xref ref-type="bibr" rid="b8-opth-3-671">8</xref> If the cataract develops after vitrectomy, subsequent cataract surgery is more challenging than when the lens is removed at the time of combined surgery. Difficulties and risks involved cataract extraction as zonular dehiscence, increased mobility of the posterior capsule, extremely deep anterior chamber during phacoemulsification, and loss of the nuclear fragments inside the vitreous cavity.<xref ref-type="bibr" rid="b9-opth-3-671">9</xref>&#x02013;<xref ref-type="bibr" rid="b13-opth-3-671">13</xref></p><p>Classically, lens removal in conjunction with vitrectomy can be managed with pars plana lensectomy by phacofragmatome, the retention of the anterior lens capsule and the introduction of a posterior chamber lens in front of the capsule. This technique is available with 20-gauge vitrectomy, and the combined surgery hastens and simplifies the visual recovery of patients in whom cataracts will predictably develop after vitrectomy.</p><p>However, there is a new vitrectomy technique, transconjunctival sutureless vitrectomy (TSV 25), introduced in 2001, which has become widely adopted for vitreoretinal surgery. With this new technique there is no 25-gauge phacofragmentation tip, so a combination of phacoemulsification and 25-gauge vitrectomy is needed in these cases.<xref ref-type="bibr" rid="b14-opth-3-671">14</xref>,<xref ref-type="bibr" rid="b15-opth-3-671">15</xref></p><p>The aim of the present study is to determine the differences observed between two groups of patients, the first submitted to 25-gauge vitrectomy combined with clear corneal phacoemulsification, and the second submitted to 20-gauge vitrectomy combined with pars plana phacofragmentation (lensectomy).</p></sec><sec sec-type="methods"><title>Methods</title><sec sec-type="methods"><title>Design</title><p>A prospective study of a sample of 987 eyes of 661 patients who needed a pars plana vitrectomy in combination with lens extraction, selected according to the inclusion criteria, and randomly divided into a two groups; the first including 486 eyes of 331 patients submitted to 25-gauge transconjunctival vitrectomy combined with clear corneal phacoemulsification, and the second including 501 eyes of 320 patients submitted to 20-gauge vitrectomy and phacofragmentation via pars plana. The recruitment dates extended from January 1st, 2003 to December 31st, 2008.</p></sec><sec><title>Setting</title><p>The Hospital St. Joan is the only public ophthalmic center in Reus, Spain, with a dependent population of 389,471 inhabitants.</p></sec><sec><title>Ethical adherence</title><p>The study was carried out in keeping with local legal requirements (approval by the local ethical committee of Hospital Universitario Sant Joan &#x02013; Reus) and in accordance with the revised guidelines of the Declaration of Helsinki. The nature of the study was explained and all patients gave written consent to participate.</p></sec><sec><title>Diagnostic criteria</title><p>The time for phacoemulsification/lensectomy is defined as the time that the surgeon needed between opening the lens and the end of cataract extraction. We divided the time of vitrectomy into three steps. The time for surgical opening was defined as the interval between the first instrument contacting the conjunctiva through to the placement of all cannulae and the infusion line. The closing time was defined as the time required for removing the cannulae and infusion line. The operative time was defined as the interval between the opening and closing times.</p><p>The main outcome measures were the incidence of intraoperative or postoperative complications. Persistent vitreous postoperative hemorrhage was defined as the presence noted within the first postoperative week. Hypotony was defined as an intraocular pressure of less than 8 mmHg. Lens opacities were classified according to the lens opacities classification system III.<xref ref-type="bibr" rid="b16-opth-3-671">16</xref> Postoperative ocular irritation has been evaluated subjectively, by questionnaire, at 24 hours, seven days, and 15 days. All patients were asked the following question: &#x0201c;Do you have a sensation of foreign body in your eye?&#x0201d; The answer could be none or mild, moderate, or severe.</p><p>Also, an objective evaluation of the conjunctival hyperemia was performed in the following way:
<list list-type="bullet"><list-item><p>None or mild hyperemia, if none or minimal conjunctival vessels are dilated.</p></list-item><list-item><p>Moderate, if vessels are more ingurgitated.</p></list-item><list-item><p>Severe, if hemorrhages are present.</p></list-item></list></p><p>Inclusion criteria for the cataract extraction.</p><list list-type="bullet"><list-item><p>Patients with a cataract that makes retina visualization difficult, with a nuclear opacity &#x02265;NO3, NC3, and/or cortical opacity &#x02265;C3, and/or subcapsular opacity &#x02265;P3</p></list-item><list-item><p>All patients aged &#x02265;60 years.</p></list-item></list><p>Exclusion criteria for the study.</p><list list-type="bullet"><list-item><p>Patients that had previously undergone intraocular surgery.</p></list-item><list-item><p>Patients who presented surgical diagnosis of proliferative vitreoretinopathy associated detachments, extensive diabetic retinal proliferation or tractional detachment.</p></list-item><list-item><p>Patients with retinal detachment, or giant retinal tears.</p></list-item><list-item><p>Patients with glaucoma (chronic open angle, neovascular, or previous closed-angle glaucoma).</p></list-item><list-item><p>Patients who needed silicone oil infusion at the end of surgery.</p></list-item></list><p>The distribution of diagnosis indicating surgical intervention for both surgical groups is listed in <xref ref-type="table" rid="t1-opth-3-671">Table 1</xref>.</p></sec><sec><title>Patient examination</title><p>Visual acuity was measured using the standard Snellen methods. All visual acuity values were converted to logarithm of the minimum angle of resolution (logMAR) scores, where each 0.1 logMAR unit represents one line of visual acuity. Off the chart visual acuity designated as counting fingers, hand motions or light perception were assigned logMAR values of 1.6, 1.9, or 2.2, respectively, according to previously established conventions.<xref ref-type="bibr" rid="b17-opth-3-671">17</xref> Intraocular pressure (IOP) values were measured the day before surgery by Goldman tonometer.</p><p>Anterior segment photography was obtained in order to evaluate the lens opacity, according to the LOCS III system.</p><p>Before cataract surgery all patients underwent a fundus retinography, if possible, using a fundus camera. The macular area was examined with a noncontact 70-diopter fundus lens. Fluorescein angiography and optical coherence tomography was performed in patients with macular epiretinal membrane, macular diabetic edema and macular hole if the lens are clear enough. The interpretation of these explorations was made by an independent investigator.</p><p>There was a follow-up control of patients after surgery at 24 hours, one week, 15 days, one month, three months, and every six months thereafter. As a control, patients were submitted to the visual acuity and IOP measures, anterior segment biomicroscopic exploration, and fundus exploration with retinography and non contact lens macular exploration.</p></sec><sec><title>Surgery</title><p>Both 25-gauge + phacoemulsification and 20-gauge + phacofragmentation surgery were performed by one of two consultants (PR-A, MB-B) in standard fashion at a single centre, both surgeons had previously performed at least 50 25-gauge vitrectomies. At the end of the study the differences between the number and type of procedure performed by the surgeons were not statistically significant.</p><p>Preoperative dilating regimen included, for both techniques, a mixture of 2.5% phenylephrine and 0.5% tropicamide, instilled three times at 30-minute intervals two hours before surgery. All patients received sedation and local anesthetic consisting of 5 ml of a retrobulbar injection of a 50:50 mixture of 2% mepivacine and 0.75% bupivicaine. Supplementary anaesthetic was administered as necessary. Patients&#x02019; skin and lashes and the ocular surface were prepared with 5% povidine-iodine solution.</p><p>Group 1 patients submitted to 25-gauge vitrectomy combined to phacoemulsification. In the first step, the trocar of the infusion sclerotomy was located 3.5 mm behind the limbus, and the infusion is turned off. The second step was the phacoemulsification surgical procedure, a technique that included a superior limbal 2.8 mm incision, phacoemulsification of the cataract and in the bag implantation of a hydrophilic acrylic lens (Akreos<sup>&#x000ae;</sup>). The wound was sutured with a point of 10-0 nylon, and viscoelastic (Amvisc Plus<sup>&#x000ae;</sup>). The third step was the three port 25-gauge vitrectomy, a technique that consisted of the lateral displacement of conjunctiva in the two sites where the trocars would be placed at the conclusion of the procedure. The trocars were withdrawn and the conjunctiva was pushed laterally with a cotton bud, applying pressure for few seconds over the sclera. Finally the viscoelastic was removed from the anterior chamber by aspiration.</p><p>Group 2 patients submitted to 20-gauge pars plana vitrectomy combined with lensectomy (phacofragmentation). A 4 mm infusion cannula was placed through a sclerotomy located 3.5 mm behind the limbus. Once the infusion had been started, two additional sclerotomies were made at the 2:30 and 9:30 clock positions; from each of these sclerotomies, the blade was directed into the nucleus lens through the equator, a fragmentation tip was passed through the nucleus and a classic lensectomy was performed, the anterior capsule was preserved safely. The second step was the posterior vitrectomy and intravitreous manoeuvres that needed the patient. The sclerotomies were sutured at the end of surgery by 7-0 vicryl. Finally a sulcus lens (Meridian HP60M<sup>&#x000ae;</sup>), was inserted via clear corneal 3.2 mm incision, the corneal wound was sutured by a point of 10-0 Nylon.</p><p>Gas-fluid exchange was performed only in the patients with macular hole. A Bausch and Lomb (Rochester, NY) Millennium system was utilized in all cases.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>For the statistical analysis, two groups of patients were formed:
<list list-type="bullet"><list-item><p>Group 1 patients submitted to 20-gauge pars plana vitrectomy combined with lensectomy (phacofragmentation).</p></list-item><list-item><p>Group 2 patients submitted to 25-gauge vitrectomy combined with phacoemulsification.</p></list-item></list></p><p>Descriptive statistics were created using SPSS statistical software (version 17.0; SPSS Inc, Chicago, IL, USA). Values are expressed as mean &#x000b1; standard deviation, and statistical significance was determined using the Student&#x02019;s <italic>t</italic>-test for paired data. Student&#x02019;s paired test was used to compare the quantitative data as:
<list list-type="bullet"><list-item><p>Visual acuity.</p></list-item><list-item><p>Current age.</p></list-item><list-item><p>Postoperative IOP.</p></list-item><list-item><p>Surgical time.</p></list-item></list></p><p>Best-corrected acuity was converted to LogMAR values to allow for statistical analysis.</p><p>When possible, intraoperative and postoperative complications were assessed by statistical analysis. Various statistical tests such as paired Student <italic>t</italic>-test for quantitative data and chi-squared analysis for qualitative data were used to compare means and assess contingencies between groups.</p><p>In all cases, <italic>P</italic>-values of less than 0.05 were considered statistically significant. We also determined the values of the odds ratio with a confidence interval of 95%.</p></sec></sec><sec sec-type="results|discussion"><title>Results and discussion</title><sec sec-type="results"><title>Results</title><sec sec-type="methods"><title>Demographic data</title><p>All 987 patients completed the study and the mean follow-up was 18.35 &#x000b1; 1.65 months (7&#x02013;34 months) for group 1, and 18.17 &#x000b1; 1.72 for group 2 (8&#x02013;36 months). The preoperative demographic data of the patients is listed in <xref ref-type="table" rid="t1-opth-3-671">Table 1</xref>. Mean age in group 1 was 68.29 &#x000b1; 9.59 (53&#x02013;88) years and for group 2 was 69.34 &#x000b1; 9.21 (55&#x02013;90) years. Group 1 comprised 54.93% men and 46.07% women, and group 2 comprised 52.87% men and 47.13% women.</p></sec><sec><title>Visual acuity</title><p>The best preoperative corrected visual acuity was 0.20 &#x000b1; 0.13 (hand motion to 0.40) in group 1 and 0.22 &#x000b1; 0.18 (hand motion to 0.40) in group 2.</p><p>Mean visual acuity in group 1 at the end of the study was 0.39 &#x000b1; 0.26 (hand motion to 0.80), LogMAR: +0.41 &#x000b1; +0.67 (+1.7&#x02013;0).</p><p>Mean visual acuity in group 2 at the end of the study was 0.38 &#x000b1; 0.28 (hand motion to 0.80), LogMAR: +0.43 &#x000b1; +0.61 (+1.7&#x02013;0.1).</p><p>Final visual acuity for both groups was well correlated to the diagnostic pathology, and the differences between the two groups are not statistically significant.</p></sec><sec><title>Variations in the surgery time (<xref ref-type="table" rid="t2-opth-3-671">Table 2</xref>)</title><p>The time taken for cataract extraction was similar in both groups of patients and the differences were not significant, but the vitrectomy time was less in patients submitted to 25-gauge vitrectomy. The total time of the surgery was less in group 1 (35.16 &#x000b1; 3.49 minutes) than in group 2 (44.74 &#x000b1; 5.33 minutes). These differences were more important in the initial time (sclerotomies versus insertions of trocars) and in the closing time because the extractions of the trocars was faster than closing the sclerotomies by sutures. It is important to observe that the operation time was longer in 25-gauge vitrectomy (23.17 &#x000b1; 0.97 minutes) than in 20-gauge vitrectomy (20.88 &#x000b1; 0.45 minutes). These findings were obvious because the aspiration-cutting time in 25-gauge was inferior to the 20-gauge vitrectomy, differences which were significant in the statistical analysis with more advantage for 20-gauge system.</p></sec><sec><title>Intraoperative complications (<xref ref-type="table" rid="t3-opth-3-671">Table 3</xref>)</title><p>The more frequent intraoperative complication is the 9.26% alteration rate in the depth of the anterior chamber in group 1. These changes may be attributed to the fact that the anterior chamber was not completely closed, because the phacoemulsification had been performed before the vitrectomy, despite a 10-0 nylon suture being leased in the wound and the anterior chamber being filled with viscoelastic. The techniques used during vitrectomy, and possible changes in the vitreous pression may have produced variations in the contents of the anterior chamber. In addition, these variations are the cause of the miosis that has been more frequently observed in group 1. An important finding is that an intraoperative number of retinal tears were observed more frequently in group 2. Perhaps a major traction of the vitreous base by 20-gauge instruments was the cause of this, although we have to bear in mind that the intraoperative tears were more observed in patients with macular hole as diagnostic pathology.</p></sec><sec><title>Postoperative complications (<xref ref-type="table" rid="t3-opth-3-671">Table 3</xref>)</title><p>The most important differences in postoperative complications between the two groups of patients correlated well with the major intraoperative complications, such as the alterations of the deep chamber in group 1 and the fact that the sclerotomies in 25-gauge vitrectomy were not sutured at the end of the surgery. As we may observe in group 1, corneal edema is more frequent, such as the postoperative hypotony, and choroidal effusion (which was observed in 1 patient in group 1). These findings in the group 2 presented a more frequent development of retinal detachment, retinal tears, and decentration of the lens.</p><p>The other postoperative complications were not statistically different between groups, with a similar rate of postoperative vitreous hemorrhage, rubeosis iridis, and postoperative cystoid macular edema.</p></sec></sec><sec><title>Changes in the IOP (<xref ref-type="table" rid="t4-opth-3-671">Table 4</xref>, <xref ref-type="fig" rid="f1-opth-3-671">Figure 1</xref>)</title><p>The changes in the of postoperative IOP are greater in the group of patients after 25-gauge vitrectomy, as shown in <xref ref-type="table" rid="t4-opth-3-671">Table 4</xref> and after the seventh day we can consider that the IOP has been recovered, and its values are normal. The differences between the two groups are significant in the statistical analysis.</p><sec><title>Comfort and inflammation (<xref ref-type="table" rid="t5-opth-3-671">Table 5</xref>)</title><p>The patients in group 1 had poor sensation of foreign body since the first day postsurgery. These findings agree with the hyperemia visualization of the conjunctiva. Group 2 presented a more frequent sensation of foreign body.</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The big advantage of combined surgery is that a single intervention can repair all current and likely significant future intraocular diseases for the patient. If surgery is done sequentially, a likely scenario is for the patient to gradually lose vision due to a formation of cataracts possibly up to 80%.<xref ref-type="bibr" rid="b6-opth-3-671">6</xref>&#x02013;<xref ref-type="bibr" rid="b8-opth-3-671">8</xref> On the other hand the drawbacks to combined surgery is in young patients with intact accommodation. Other disadvantages include increased opening time, and a tendency to cause more inflammation, especially in patients who require gas and laser.</p><p>The introduction of 25-gauge vitrectomy in 2001 represented a revolutionary advance in posterior segment surgery, that simplified opening and closing of the eye, minimized surgical trauma for the patient, and made postsurgical recovery faster and less painful.<xref ref-type="bibr" rid="b18-opth-3-671">18</xref>&#x02013;<xref ref-type="bibr" rid="b20-opth-3-671">20</xref> Despite these advantages, if we want to combine lens extraction surgical phacofragmentation, the tips do not exist. In order to perform lens extraction via pars plana, the phacoemulsification is the technique of choice,<xref ref-type="bibr" rid="b21-opth-3-671">21</xref>,<xref ref-type="bibr" rid="b22-opth-3-671">22</xref> but there are many difficulties in combining the 25-gauge vitrectomy with phacoemulsification.</p><p>In the cataract extraction step, we observed that the mean time of the surgery between the two groups is similar, and the difference was not significant. In the intervention technique it is important to note that in group 1 the insertion of the first trocar (the trocar of the infusion canula, in the inferotemporal) is important in order to facilitate the posterior insertion of the two other trocars after the phacoemulsification step if it hadn&#x02019;t been implanted before. Insertion after phacoemulsification is difficult because the eyes are hypotense. In group 2, the pars plana lensectomy may lead to loose fragments of the lens entering the vitreous, but in this event in our series this fragments has not made the vitrectomy difficult.</p><p>In group 1, the location of the intraocular lens (IOL) implant is important, and the insertion is into the capsular bag, but in group 2 the location of the IOL was in the sulcus. This implantion has caused the decentration observed in 2.38% of the series. This problem can be avoided if the lensectomy is substituted for phacoemulsification by clear cornea in group 2, as described in the literature.<xref ref-type="bibr" rid="b23-opth-3-671">23</xref>&#x02013;<xref ref-type="bibr" rid="b27-opth-3-671">27</xref></p><p>There are many differences between groups in respect to the time taken for the vitrectomy. The most important advantage of group 1 is the reduction of the mean time of the vitrectomy phase. This reduction occurred in the initial and closing phases of the vitrectomy, despite the vitrectomy operation time being greater in group 2. In the operation time the authors should be indicate that one of the major problem with 25-gauge vitrectomy is the flexibility of the instruments that hampers thorough removal of most of the peripheral vitreous.<xref ref-type="bibr" rid="b28-opth-3-671">28</xref>&#x02013;<xref ref-type="bibr" rid="b30-opth-3-671">30</xref> The introduction of the new 23-gauge technique may avoid this problem.<xref ref-type="bibr" rid="b31-opth-3-671">31</xref>&#x02013;<xref ref-type="bibr" rid="b35-opth-3-671">35</xref></p><p>In our series one of the major problems during the vitrectomy was the change observed in the depth of the anterior chamber. Despite the presence of viscoelastic, these variations worsened the vision of the retina, and may be the cause of postoperative corneal edema observed in 4.93% in group 1 against 1.19% of patients in group 2.</p><p>Also the anterior chamber depth may worsen mydriasis. An excellent pupillary dilatation is an essential prerequisite to safe and successful vitreoretinal surgery. An inadequate mydriasis makes the vitrectomy difficult, as we have observed in this series. The patients submitted to phacoemulsification plus 25-gauge vitrectomy had more frequent pupillary constriction (6.17%) than patients of group 2 (1.79%). This finding is probably due to the changes in the depth of the anterior chamber observed in group 1.</p><p>One important finding in postoperative time is the presence of IOL decentration observed in patients of group 2. The implantation of a lens in the sulcus and not in the capsular bag is disadvantageous and causes the decentration. Compared with pars plana lensectomy, phacoemulsification offers the benefit of allowing the IOL to be placed in the capsular bag.</p><p>Hypotony in our series was experienced by 2.47% of the patients and choroidal effusion appeared in one patient (0.02%). We defined hypotony as the presence of IOP &#x0003c; 8 mmHG in the postoperative period. The majority of the patients recovered normal IOP without any intervention; only one required a suture of the sclerotomies. Only one sclerotomy patient presented a wound leakage in the superotemporal sclerotomy after the surgery, this patient was also the patient with choroidal effusion, which recovered after the suture of sclerotomy. In our series there is a greater reduction in the IOP after the 25-gauge vitrectomy than after 20-gauge vitrectomy, as shown in <xref ref-type="table" rid="t4-opth-3-671">Table 4</xref> and <xref ref-type="fig" rid="f1-opth-3-671">Figure 1</xref>. For all diagnostic pathology, the IOP decreased more in the first group of patients. The IOP got back to normal after one month and the differences between the groups were not significant.<xref ref-type="bibr" rid="b19-opth-3-671">19</xref>,<xref ref-type="bibr" rid="b20-opth-3-671">20</xref>,<xref ref-type="bibr" rid="b30-opth-3-671">30</xref>,<xref ref-type="bibr" rid="b36-opth-3-671">36</xref> Hypotony, even if transient, is not a benign condition and may increase the risks of serious complications postoperation, including retinal or vitreal incarceration, suprachoroidal hemorrhage, and endophthalmitis.<xref ref-type="bibr" rid="b18-opth-3-671">18</xref>,<xref ref-type="bibr" rid="b37-opth-3-671">37</xref> There is evidence in the literature that 25-gauge sclerotomy frequently does not self-seal.</p><p>No endophthalmitis has been observed in our series, despite there being a theoretical possibility that sutureless sclerotomy may serve as a conduit for the entry of bacteria into the eye postoperation. Covering the sites of sclerotomies by conjunctiva should serve as a barrier to the entry of these germs.<xref ref-type="bibr" rid="b38-opth-3-671">38</xref>&#x02013;<xref ref-type="bibr" rid="b41-opth-3-671">41</xref> In the literature there is a description of a high rate of endophthalmitis in 25-gauge against 20-gauge vitrectomy.<xref ref-type="bibr" rid="b42-opth-3-671">42</xref> Kunimoto and colleagues reported one case of endophthalmitis in 5,498 eyes (0.018%) vitrectomized by 20-gauge against seven cases in 3,103 eyes (0.23%) who underwent 25-gauge vitrectomy. In the literature, the presence of postoperative retinal tears or retinal detachment has more frequently been reported in patients submitted to 25-gauge vitrectomy. Ibarra and colleagues<xref ref-type="bibr" rid="b43-opth-3-671">43</xref> reported a prevalence of 4.4% in their series, and Fujii and colleagues<xref ref-type="bibr" rid="b15-opth-3-671">15</xref> reported a prevalence of 2%. In spite of these published studies,<xref ref-type="bibr" rid="b15-opth-3-671">15</xref>,<xref ref-type="bibr" rid="b43-opth-3-671">43</xref>&#x02013;<xref ref-type="bibr" rid="b45-opth-3-671">45</xref> in our series the presence of intraoperative and postoperative retinal tears are not more frequent in 25-gauge vitrectomy. In fact we may observe a major presence of retinal tears in the 20-gauge vitrectomy group. The authors think that minor traction over the vitreous base carried out in the 25-gauge system may prevent the appearance of retinal tears, and the small size of the postoperative sclerotomy performed in 25-gauge may be the cause of the minor postoperative contraction of the vitreous base around the wound. It is important to indicate that in the literature a high number of postoperative retinal tears and detachments have been observed in patients diagnosed with macular hole, in agreement with our series.<xref ref-type="bibr" rid="b43-opth-3-671">43</xref>,<xref ref-type="bibr" rid="b44-opth-3-671">44</xref></p><p>The results of the present study show that visual acuity outcomes are similar in both groups. Preoperative and postoperative complications are not excessively distinct in both groups, and the differences may be attributed to the technique used in each case. Thus group 1 presents more complications attributed to the extraction of cataract via clear cornea, with the consequent loss of the anterior chamber depth. Group 2 has more frequent complications in the IOL decentration. It is important that in our series no cases of endophthalmitis have been observed, but this may be because of the small sample size, in other series with more patients the endophthalmitis appeared and is more frequent than in 20-gauge vitrectomy.<xref ref-type="bibr" rid="b45-opth-3-671">45</xref>,<xref ref-type="bibr" rid="b46-opth-3-671">46</xref> In postoperative retinal tears, we did not show an increase in group 1 as we may expect according to the published data. It is important to remark that the mean time of surgery and postoperative inflammation are advantages for group 1. The authors think that careful patient selection is critical to a successful combined surgery. In the present study, both techniques have a similar number of complications and have similar postoperative outcomes, and are valid for the management of the pathologies selected.</p><p>This study is limited because it is a case series study, despite its prospective and randomized technique, with a limited number of eyes that may become a handicap. This factor may affect the low prevalence of some complications such as, endophthalmitis or retinal detachment. This study was not designed to assess comparative visual change nor standardized best-corrected ETDRS measurements made. Finally, long-term complications may appear and may not be detected with follow-up. In the present study, the follow-up of 18.35 &#x000b1; 1.65 months may have been insufficient depending on the postoperative complication. Further studies including a cumulative multicenter analysis is called for. A case for selection of surgical pathology remains important in order to select the best surgical method for each patient.</p></sec><sec><title>Conclusion</title><p>In the present study, both techniques have a similar number of complications and have a similar postoperative outcome, and are valid for the management of the pathologies selected. These complications may be attributed to the different systems employed in each group of patients.</p></sec></body><back><fn-group><fn><p><bold>Disclosures</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-opth-3-671"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machemer</surname><given-names>R</given-names></name><name><surname>Parel</surname><given-names>JM</given-names></name><name><surname>Norton</surname><given-names>EW</given-names></name></person-group><article-title>Vitrectamy: a pars plana approacn. Technical improvements and further results</article-title><source>Trans Am Acad Ophthalmal Otolaryngol</source><year>1972</year><volume>76</volume><fpage>462</fpage><lpage>466</lpage></mixed-citation></ref><ref id="b2-opth-3-671"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machemer</surname><given-names>R</given-names></name></person-group><article-title>A new concept for vitreous surgery. Two instrument techniques in pars plana vitrectomy</article-title><source>Arch Opnthalmal</source><year>1974</year><volume>92</volume><fpage>407</fpage><lpage>412</lpage></mixed-citation></ref><ref id="b3-opth-3-671"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowas</surname><given-names>NG</given-names></name></person-group><article-title>Pars plana vitrectomy microsurgical pars plana lensecomy</article-title><source>Trans Sect Ophthalmol Am Acad Ophthalmol Otorlaryngol</source><year>1976</year><volume>81</volume><fpage>371</fpage><lpage>381</lpage></mixed-citation></ref><ref id="b4-opth-3-671"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenship</surname><given-names>GW</given-names></name><name><surname>Cortez</surname><given-names>R</given-names></name><name><surname>Machemer</surname><given-names>R</given-names></name></person-group><article-title>The lens and pars plana vitectomy for diabetic retinopathy complications</article-title><source>Arch Ophthalmol</source><year>1979</year><volume>97</volume><fpage>1263</fpage><lpage>1267</lpage><pub-id pub-id-type="pmid">454259</pub-id></mixed-citation></ref><ref id="b5-opth-3-671"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenship</surname><given-names>GW</given-names></name></person-group><article-title>The lens influence on diabetic vitrectomy results. Report of a prospective randomized study</article-title><source>Arch Ophthalmol</source><year>1980</year><volume>98</volume><fpage>2196</fpage><lpage>2198</lpage><pub-id pub-id-type="pmid">7447772</pub-id></mixed-citation></ref><ref id="b6-opth-3-671"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenship</surname><given-names>GW</given-names></name><name><surname>Machemer</surname><given-names>R</given-names></name></person-group><article-title>Long-term diabetic vitrectomy results; report of 10 year follow-up</article-title><source>Ophthalmology</source><year>1985</year><volume>92</volume><fpage>503</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">2582329</pub-id></mixed-citation></ref><ref id="b7-opth-3-671"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bustros</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>JT</given-names></name><name><surname>Michels</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Nuclear sclerosis after virectomy for idiopatic epiretinal membranes</article-title><source>Am J Ophthalmol</source><year>1988</year><volume>7</volume><fpage>160</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">3341433</pub-id></mixed-citation></ref><ref id="b8-opth-3-671"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>MA</given-names></name><name><surname>Rice</surname><given-names>TA</given-names></name><name><surname>Michels</surname><given-names>RG</given-names></name><name><surname>Auer</surname><given-names>C</given-names></name></person-group><article-title>The crystalline lens after vitrectomy for diabetic retinopathy</article-title><source>Ophthalmology</source><year>1984</year><volume>91</volume><fpage>1480</fpage><lpage>1484</lpage><pub-id pub-id-type="pmid">6521988</pub-id></mixed-citation></ref><ref id="b9-opth-3-671"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biro</surname><given-names>Z</given-names></name><name><surname>Kovacs</surname><given-names>B</given-names></name></person-group><article-title>Results of cataract surgery in previously vitrectomized eyes</article-title><source>J Cataract Refract Surg</source><year>2002</year><volume>28</volume><fpage>1003</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">12036644</pub-id></mixed-citation></ref><ref id="b10-opth-3-671"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname><given-names>ML</given-names></name><name><surname>Puklin</surname><given-names>JE</given-names></name><name><surname>Abrams</surname><given-names>GW</given-names></name><name><surname>Eliott</surname><given-names>D</given-names></name></person-group><article-title>Phacoemulsification for cataract following pars plana vitrectomy</article-title><source>Ophthalmic Surg Lasers</source><year>1997</year><volume>28</volume><fpage>558</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">9243658</pub-id></mixed-citation></ref><ref id="b11-opth-3-671"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grusha</surname><given-names>YO</given-names></name><name><surname>Masket</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>KM</given-names></name></person-group><article-title>Phacoemulsification and lens implantation after pars plana vitrectomy</article-title><source>Ophthalmology</source><year>1998</year><volume>105</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">9479289</pub-id></mixed-citation></ref><ref id="b12-opth-3-671"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahfat</surname><given-names>FG</given-names></name><name><surname>Yuen</surname><given-names>CH</given-names></name><name><surname>Groenewald</surname><given-names>CP</given-names></name></person-group><article-title>Phacoemulsification and intraocular lens implantation following pars plana vitrectomy: a prospective study</article-title><source>Eye</source><year>2003</year><volume>17</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12579164</pub-id></mixed-citation></ref><ref id="b13-opth-3-671"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunstein</surname><given-names>RE</given-names></name><name><surname>Airiani</surname><given-names>S</given-names></name></person-group><article-title>Cataract surgery results after pars plana vitrectomy</article-title><source>Curr Opin Ophthalmol</source><year>2003</year><volume>14</volume><fpage>150</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">12777934</pub-id></mixed-citation></ref><ref id="b14-opth-3-671"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>GY</given-names></name><name><surname>de Juan</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Humayun</surname><given-names>MS</given-names></name><etal/></person-group><article-title>A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><fpage>1807</fpage><lpage>1812</lpage><pub-id pub-id-type="pmid">12359598</pub-id></mixed-citation></ref><ref id="b15-opth-3-671"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>GY</given-names></name><name><surname>de Juan</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Humayun</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="pmid">12359600</pub-id></mixed-citation></ref><ref id="b16-opth-3-671"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chylack</surname><given-names>LT</given-names><suffix>Jr</suffix></name><name><surname>Wolfe</surname><given-names>JK</given-names></name><name><surname>Singer</surname><given-names>DM</given-names></name><etal/></person-group><article-title>The lens classification system III. The longitudinal study of cataract study group</article-title><source>Arch Ophthalmol</source><year>1993</year><volume>111</volume><fpage>831</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">8512486</pub-id></mixed-citation></ref><ref id="b17-opth-3-671"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westheimer</surname><given-names>G</given-names></name></person-group><article-title>Scaling of visual acuity measurements</article-title><source>Arch Ophthalmol</source><year>1979</year><volume>97</volume><fpage>327</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">550809</pub-id></mixed-citation></ref><ref id="b18-opth-3-671"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>E</given-names></name></person-group><article-title>25-gauge transconjunctival sutureless vitrectomy</article-title><source>Curr Opin Ophthalmol</source><year>2007</year><volume>18</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">17435424</pub-id></mixed-citation></ref><ref id="b19-opth-3-671"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakhanpal</surname><given-names>RR</given-names></name><name><surname>Humayun</surname><given-names>MS</given-names></name><name><surname>de Juan</surname><given-names>E</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease</article-title><source>Ophthalmology</source><year>2005</year><volume>112</volume><fpage>817</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">15878061</pub-id></mixed-citation></ref><ref id="b20-opth-3-671"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarra</surname><given-names>MS</given-names></name><name><surname>Hermel</surname><given-names>M</given-names></name><name><surname>Prenner</surname><given-names>JL</given-names></name><name><surname>Hassan</surname><given-names>TS</given-names></name></person-group><article-title>Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy</article-title><source>Am J Ophthalmol</source><year>2005</year><volume>139</volume><fpage>831</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">15860288</pub-id></mixed-citation></ref><ref id="b21-opth-3-671"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Monta&#x000f1;es</surname><given-names>J</given-names></name><name><surname>Barrio-Barrio</surname><given-names>J</given-names></name><name><surname>Garcia-layana</surname><given-names>A</given-names></name></person-group><article-title>Combined cataract surgery and 25-gauge sutureless vitrectomy for posterior lentiglobus</article-title><source>J Cataract Refract Surg</source><year>2007</year><volume>33</volume><fpage>380</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">17321385</pub-id></mixed-citation></ref><ref id="b22-opth-3-671"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>JU</given-names></name><name><surname>Yoon</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name></person-group><article-title>Combined phacoemulsification, foldable intraocular lens implantation, and 25-gauge transconjunctival sutureless vitrectomy</article-title><source>J Cataract Refract Surg</source><year>2006</year><volume>32</volume><fpage>727</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">16765787</pub-id></mixed-citation></ref><ref id="b23-opth-3-671"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CJ</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Chiang</surname><given-names>SY</given-names></name><name><surname>Lin</surname><given-names>LT</given-names></name></person-group><article-title>Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases</article-title><source>J Cataract Refract Surg</source><year>2005</year><volume>31</volume><fpage>1198</fpage><lpage>1207</lpage><pub-id pub-id-type="pmid">16039498</pub-id></mixed-citation></ref><ref id="b24-opth-3-671"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demetriades</surname><given-names>AM</given-names></name><name><surname>Gottsch</surname><given-names>JD</given-names></name><name><surname>Thomsen</surname><given-names>R</given-names></name><etal/></person-group><article-title>Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology</article-title><source>Am J Ophthalmol</source><year>2003</year><volume>135</volume><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12614744</pub-id></mixed-citation></ref><ref id="b25-opth-3-671"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schorwey</surname><given-names>K</given-names></name><name><surname>Pavlovic</surname><given-names>S</given-names></name><name><surname>Jacobi</surname><given-names>KW</given-names></name></person-group><article-title>Combind clear corneal phacoemulsification, vitreoretinal surgery, and intaocular lens implantation</article-title><source>J Cataract Refract Surg</source><year>1999</year><volume>25</volume><fpage>693</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">10330647</pub-id></mixed-citation></ref><ref id="b26-opth-3-671"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahey</surname><given-names>JM</given-names></name><name><surname>Francis</surname><given-names>RR</given-names></name><name><surname>Kearney</surname><given-names>JJ</given-names></name></person-group><article-title>Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases</article-title><source>Ophthalmology</source><year>2003</year><volume>110</volume><fpage>1335</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">12867387</pub-id></mixed-citation></ref><ref id="b27-opth-3-671"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahey</surname><given-names>JM</given-names></name><name><surname>Francis</surname><given-names>RR</given-names></name><name><surname>Kearney</surname><given-names>JJ</given-names></name><name><surname>Cheung</surname><given-names>M</given-names></name></person-group><article-title>Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy</article-title><source>Curr Opin Ophthalmol</source><year>2004</year><volume>15</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">15118505</pub-id></mixed-citation></ref><ref id="b28-opth-3-671"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>JE</given-names></name><name><surname>Akduman</surname><given-names>L</given-names></name></person-group><article-title>Incidence of complications in 25-gauge transconjunctival sutureless vitrectomy based on the surgical indications</article-title><source>Ophthalmic Surg Lasers Imaging</source><year>2007</year><volume>38</volume><fpage>100</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">17396688</pub-id></mixed-citation></ref><ref id="b29-opth-3-671"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahar</surname><given-names>I</given-names></name><name><surname>Axer-Siegel</surname><given-names>R</given-names></name><name><surname>Weinberger</surname><given-names>D</given-names></name></person-group><article-title>Pars plana vitrectomy: comparison of three techniques for the treatment of diabetic vitreous hemorrhage</article-title><source>Ophthalmic Surg Lasers Imaging</source><year>2006</year><volume>37</volume><fpage>364</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">17017195</pub-id></mixed-citation></ref><ref id="b30-opth-3-671"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byeon</surname><given-names>SH</given-names></name><name><surname>Chu</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery</article-title><source>Ophthalmologica</source><year>2006</year><volume>220</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">16785758</pub-id></mixed-citation></ref><ref id="b31-opth-3-671"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>P</given-names></name><name><surname>Salvat</surname><given-names>M</given-names></name><name><surname>Almena</surname><given-names>A</given-names></name><etal/></person-group><article-title>Experience with 25-gauge transconjunctival vitrectomy compared to a 20-gauge system. Analysis of 132 cases</article-title><source>J Fr Ophtalmol</source><year>2006</year><volume>29</volume><fpage>1025</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">17114996</pub-id></mixed-citation></ref><ref id="b32-opth-3-671"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckardt</surname><given-names>C</given-names></name></person-group><article-title>Transconjunctival sutureless 23-gauge vitrectomy</article-title><source>Retina</source><year>2005</year><volume>25</volume><fpage>208</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">15689813</pub-id></mixed-citation></ref><ref id="b33-opth-3-671"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubschman</surname><given-names>JP</given-names></name><name><surname>Gonzalez</surname><given-names>CR</given-names></name><name><surname>Bourda</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Combined 25-and 23-gauge surgery: a new sutureless vitrectomy technique</article-title><source>Ophthalmic Surg Lasers Imaging</source><year>2007</year><volume>38</volume><fpage>345</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">17674931</pub-id></mixed-citation></ref><ref id="b34-opth-3-671"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubschman</surname><given-names>JP</given-names></name></person-group><article-title>Comparison of different vitrectomy systems (Comparaison des diff&#x000e9;rents syst&#x000e8;mes de vitrectomie)</article-title><source>Jr Fr Ophtalmol</source><year>2005</year><volume>28</volume><fpage>606</fpage><lpage>609</lpage></mixed-citation></ref><ref id="b35-opth-3-671"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>LB</given-names></name><name><surname>Reis</surname><given-names>PA</given-names></name></person-group><article-title>Silicone oil tamponade in 23-gauge transconjunctival sutureless vitrectomy</article-title><source>Retina</source><year>2007</year><volume>27</volume><fpage>1054</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">18040244</pub-id></mixed-citation></ref><ref id="b36-opth-3-671"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patelli</surname><given-names>F</given-names></name><name><surname>Radice</surname><given-names>P</given-names></name><name><surname>Zumbo</surname><given-names>G</given-names></name><etal/></person-group><article-title>G.25-gauge macular surgery: results and complications</article-title><source>Retina</source><year>2007</year><volume>27</volume><fpage>750</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">17621185</pub-id></mixed-citation></ref><ref id="b37-opth-3-671"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Chan</surname><given-names>CK</given-names></name><name><surname>Fan</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Choroidal folds after 25 gauge transconjunctival sutureless vitrectomy</article-title><source>Eye</source><year>2005</year><volume>19</volume><fpage>825</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">15359237</pub-id></mixed-citation></ref><ref id="b38-opth-3-671"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acar</surname><given-names>N</given-names></name><name><surname>Unvear</surname><given-names>YB</given-names></name><name><surname>Altan</surname><given-names>T</given-names></name><name><surname>Kabran</surname><given-names>Z</given-names></name></person-group><article-title>Acute endophthalmitis after 25-gauge sutureless vitrectomy</article-title><source>Int Ophthalmol</source><year>2007</year><volume>27</volume><fpage>361</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">17492400</pub-id></mixed-citation></ref><ref id="b39-opth-3-671"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SR</given-names></name><name><surname>Aylward</surname><given-names>GW</given-names></name></person-group><article-title>Endophtalmitis following 25-gauges vitrectomy</article-title><source>Eye</source><year>2005</year><volume>19</volume><fpage>1228</fpage><lpage>1229</lpage><pub-id pub-id-type="pmid">15543184</pub-id></mixed-citation></ref><ref id="b40-opth-3-671"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taban</surname><given-names>M</given-names></name><name><surname>Ufret-Vicentry</surname><given-names>RL</given-names></name><name><surname>Sears</surname><given-names>JE</given-names></name></person-group><article-title>Endophthalmitis after 25-gauge transconjunctival sutureless vitrectomy</article-title><source>Retina</source><year>2006</year><volume>26</volume><fpage>830</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">16963862</pub-id></mixed-citation></ref><ref id="b41-opth-3-671"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>JM</given-names></name></person-group><article-title>Wound integrity and the conjunctiva in prevention of endophthalmitis following sutureless 25-gauge vitrectomy</article-title><source>Eye</source><year>2006</year><volume>20</volume><fpage>1490</fpage><pub-id pub-id-type="pmid">16878121</pub-id></mixed-citation></ref><ref id="b42-opth-3-671"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunimoto</surname><given-names>DY</given-names></name><name><surname>Kaiser</surname><given-names>RS</given-names></name></person-group><article-title>Wills Eye Retina Service. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy</article-title><source>Ophthalmology</source><year>2007</year><volume>114</volume><fpage>2133</fpage><lpage>2137</lpage><pub-id pub-id-type="pmid">17916378</pub-id></mixed-citation></ref><ref id="b43-opth-3-671"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarra</surname><given-names>MS</given-names></name><name><surname>Hermel</surname><given-names>M</given-names></name><name><surname>Prenner</surname><given-names>JL</given-names></name><name><surname>Hassan</surname><given-names>TS</given-names></name></person-group><article-title>Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy</article-title><source>Am J Ophthalmol</source><year>2005</year><volume>139</volume><fpage>831</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">15860288</pub-id></mixed-citation></ref><ref id="b44-opth-3-671"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>A</given-names></name><name><surname>Sugivama</surname><given-names>K</given-names></name></person-group><article-title>Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2007</year><volume>245</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">16710667</pub-id></mixed-citation></ref><ref id="b45-opth-3-671"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunimoto</surname><given-names>DY</given-names></name><name><surname>Kaiser</surname><given-names>RS</given-names></name><collab>Wills Eye Service</collab></person-group><article-title>Incidence of endophthalmitis after 20- and 25-gauge vitrectomy</article-title><source>Ophthalmology</source><year>2007</year><volume>114</volume><fpage>2133</fpage><lpage>2137</lpage><pub-id pub-id-type="pmid">17916378</pub-id></mixed-citation></ref><ref id="b46-opth-3-671"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>IU</given-names></name><name><surname>Flynn</surname><given-names>HW</given-names><suffix>Jr</suffix></name><name><surname>Dev</surname><given-names>S</given-names></name><etal/></person-group><article-title>Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes</article-title><source>Retina</source><year>2008</year><volume>28</volume><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">18185150</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="f1-opth-3-671" position="float"><label>Figure 1</label><caption><p>Evolution of the mean intraocular pressure during the first month.</p></caption><graphic xlink:href="opth-3-671f1"/></fig><table-wrap id="t1-opth-3-671" position="float"><label>Table 1</label><caption><p>Description of previous pathology of the eyes submitted to 25-gauge and 20-gauge vitrectomy combined with cataract extraction</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Diagnostic</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Number of eyes (25-gauge)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Percentage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Number of eyes (20-gauge)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Percentage</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitreous hemorrhage due to diabetic retinopathy</td><td valign="top" align="left" rowspan="1" colspan="1">210</td><td valign="top" align="left" rowspan="1" colspan="1">43.20%</td><td valign="top" align="left" rowspan="1" colspan="1">212</td><td valign="top" align="left" rowspan="1" colspan="1">42.31%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitreous hemorrhage due to posterior vitreous detachment</td><td valign="top" align="left" rowspan="1" colspan="1">32</td><td valign="top" align="left" rowspan="1" colspan="1">6.83%</td><td valign="top" align="left" rowspan="1" colspan="1">34</td><td valign="top" align="left" rowspan="1" colspan="1">6.78%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitreous hemorrhage due to CRVO or branch-CRVO</td><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">3.29%</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">3.79%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Macular epiretinal membrane</td><td valign="top" align="left" rowspan="1" colspan="1">105</td><td valign="top" align="left" rowspan="1" colspan="1">21.60%</td><td valign="top" align="left" rowspan="1" colspan="1">97</td><td valign="top" align="left" rowspan="1" colspan="1">19.36%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tractional-diabetic macular edema</td><td valign="top" align="left" rowspan="1" colspan="1">57</td><td valign="top" align="left" rowspan="1" colspan="1">11.73%</td><td valign="top" align="left" rowspan="1" colspan="1">65</td><td valign="top" align="left" rowspan="1" colspan="1">12.97%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Macular hole</td><td valign="top" align="left" rowspan="1" colspan="1">53</td><td valign="top" align="left" rowspan="1" colspan="1">11.11%</td><td valign="top" align="left" rowspan="1" colspan="1">59</td><td valign="top" align="left" rowspan="1" colspan="1">11.77%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uveitis</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">3.67%</td><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">2.99%</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-opth-3-671"><p><bold>Abbreviation:</bold> CRVO, central retinal vein occlusion.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-opth-3-671" position="float"><label>Table 2</label><caption><p>Surgical time: Mean time employed in the 25-gauge vitrectomy plus phacoemulsification versus 20-gauge vitrectomy plus phacofragmentation</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Surgical step</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Phacoemulsification + 25-gauge vitrectomy n = 486</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Phacofragmentation + 20-gauge vitrectomy n = 501</bold></th><th valign="top" align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Phacoemulsification in 25-gauge/phacofragmentation in 20-gauge</td><td valign="top" align="left" rowspan="1" colspan="1">10.90 &#x000b1; 0.50 minutes</td><td valign="top" align="left" rowspan="1" colspan="1">11.30 &#x000b1; 0.40 minutes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.174</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Surgical opening time</td><td valign="top" align="left" rowspan="1" colspan="1">1.97 &#x000b1; 0.13 minutes</td><td valign="top" align="left" rowspan="1" colspan="1">5.20 &#x000b1; 0.30 minutes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.0001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Operative time</td><td valign="top" align="left" rowspan="1" colspan="1">23.17 &#x000b1; 0.97 minutes</td><td valign="top" align="left" rowspan="1" colspan="1">20.88 &#x000b1; 0.45 minutes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Closing time</td><td valign="top" align="left" rowspan="1" colspan="1">2.10 &#x000b1; 0.29 minutes</td><td valign="top" align="left" rowspan="1" colspan="1">8.24 &#x000b1; 0.40 minutes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.0001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="left" rowspan="1" colspan="1">35.16 &#x000b1; 3.49 minutes</td><td valign="top" align="left" rowspan="1" colspan="1">44.74 &#x000b1; 5.33 minutes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.01</td></tr></tbody></table></table-wrap><table-wrap id="t3-opth-3-671" position="float"><label>Table 3</label><caption><p>Intraoperative and postoperative complications in the two group of patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Complication</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Group 1 (25-gauge)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Group 2 (20-gauge)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Signification</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="4" colspan="1">Intraoperative</td><td valign="top" align="left" rowspan="1" colspan="1">Miosis</td><td valign="top" align="left" rowspan="1" colspan="1">29 (6.17%)</td><td valign="top" align="left" rowspan="1" colspan="1">9 (1.79%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Changes in the anterior chamber depth</td><td valign="top" align="left" rowspan="1" colspan="1">45 (9.26%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x02264; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anterior or posterior capsule rupture</td><td valign="top" align="left" rowspan="1" colspan="1">11 (2.35%)</td><td valign="top" align="left" rowspan="1" colspan="1">18 (3.59%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.087</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Retinal tears</td><td valign="top" align="left" rowspan="1" colspan="1">9 (1.86%)</td><td valign="top" align="left" rowspan="1" colspan="1">17 (3.59%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.020</td></tr><tr><td valign="top" align="left" rowspan="13" colspan="1">Postoperative</td><td valign="top" align="left" rowspan="1" colspan="1">Wound leak</td><td valign="top" align="left" rowspan="1" colspan="1">6 (1.23%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Retinal tears</td><td valign="top" align="left" rowspan="1" colspan="1">12 (2.47%)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (2.19%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.201</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Retinal detachment</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">7 (1.39%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.020</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypotony</td><td valign="top" align="left" rowspan="1" colspan="1">13 (2.77%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Choroidal effusions</td><td valign="top" align="left" rowspan="1" colspan="1">1 (0.02%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Opacification of the anterior or posterior capsule at six months/one year</td><td valign="top" align="left" rowspan="1" colspan="1">45 (9.25%)/132 (27.16%)</td><td valign="top" align="left" rowspan="1" colspan="1">51 (10.17%)/141 (28.14%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.143/<italic>P</italic> = 0.178</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative vitreous hemorrhage</td><td valign="top" align="left" rowspan="1" colspan="1">45 (9.26%)</td><td valign="top" align="left" rowspan="1" colspan="1">48 (9.58%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.221</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Corneal edema</td><td valign="top" align="left" rowspan="1" colspan="1">23 (4.91%)</td><td valign="top" align="left" rowspan="1" colspan="1">6 (1.19%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.020</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uveitis</td><td valign="top" align="left" rowspan="1" colspan="1">5 (1.06%)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (0.79%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.301</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Iris neovascularitzation</td><td valign="top" align="left" rowspan="1" colspan="1">2 (0.42%)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (0.59%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.203</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intraocular lens decentration</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">12 (2.38%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CME after six months of the cataract surgery</td><td valign="top" align="left" rowspan="1" colspan="1">35 (7.47%)</td><td valign="top" align="left" rowspan="1" colspan="1">34 (6.78%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.113</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-opth-3-671"><p><bold>Abbreviation:</bold> CME, cystoid macular edema.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-opth-3-671" position="float"><label>Table 4</label><caption><p>The intraocular pressure values according to the diagnosis of patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="2" colspan="1"><bold>Diagnostic</bold></th><th valign="top" align="left" colspan="4" rowspan="1"><bold>Phacoemulsification + 25-gauge vitrectomy</bold><hr/></th><th valign="top" align="left" colspan="4" rowspan="1"><bold>Phacofragmentation + 20-gauge vitrectomy</bold><hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Before surgery</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>24 hours after surgery</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>7th day</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>15th day</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Before surgery</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>24 hours after surgery</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>7th day</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>15th day</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitreous hemorrhage</td><td valign="top" align="left" rowspan="1" colspan="1">16.46 &#x000b1; 1.98<xref ref-type="table-fn" rid="tfn3-opth-3-671">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12.11 &#x000b1; 2.06</td><td valign="top" align="left" rowspan="1" colspan="1">15.70 &#x000b1; 1.59</td><td valign="top" align="left" rowspan="1" colspan="1">15.71 &#x000b1; 1.68</td><td valign="top" align="left" rowspan="1" colspan="1">16.87 &#x000b1; 1.94</td><td valign="top" align="left" rowspan="1" colspan="1">15.87 &#x000b1; 1.53</td><td valign="top" align="left" rowspan="1" colspan="1">16.06 &#x000b1; 1.36</td><td valign="top" align="left" rowspan="1" colspan="1">16.46 &#x000b1; 1.72</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tractional-diabeticmacular edema</td><td valign="top" align="left" rowspan="1" colspan="1">15.50 &#x000b1; 12.13</td><td valign="top" align="left" rowspan="1" colspan="1">11.80 &#x000b1; 2.13</td><td valign="top" align="left" rowspan="1" colspan="1">15.20 &#x000b1; 1.87</td><td valign="top" align="left" rowspan="1" colspan="1">15.80 &#x000b1; 1.87</td><td valign="top" align="left" rowspan="1" colspan="1">15.90 &#x000b1; 0.28</td><td valign="top" align="left" rowspan="1" colspan="1">15.80 &#x000b1; 2.07</td><td valign="top" align="left" rowspan="1" colspan="1">15.60 &#x000b1; 2.22</td><td valign="top" align="left" rowspan="1" colspan="1">16.20 &#x000b1; 1.91</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Macular epiretinal membrane</td><td valign="top" align="left" rowspan="1" colspan="1">15.50 &#x000b1; 1.37</td><td valign="top" align="left" rowspan="1" colspan="1">12.15 &#x000b1; 1.57</td><td valign="top" align="left" rowspan="1" colspan="1">14.33 &#x000b1; 1.63</td><td valign="top" align="left" rowspan="1" colspan="1">15.17 &#x000b1; 1.47</td><td valign="top" align="left" rowspan="1" colspan="1">15.83 &#x000b1; 1.16</td><td valign="top" align="left" rowspan="1" colspan="1">15.50 &#x000b1; 1.51</td><td valign="top" align="left" rowspan="1" colspan="1">15.33 &#x000b1; 1.21</td><td valign="top" align="left" rowspan="1" colspan="1">16.50 &#x000b1; 1.22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Macular hole</td><td valign="top" align="left" rowspan="1" colspan="1">16.45 &#x000b1; 1.12</td><td valign="top" align="left" rowspan="1" colspan="1">12.18 &#x000b1; 1.67</td><td valign="top" align="left" rowspan="1" colspan="1">14.36 &#x000b1; 1.68</td><td valign="top" align="left" rowspan="1" colspan="1">15.45 &#x000b1; 0.68</td><td valign="top" align="left" rowspan="1" colspan="1">16.81 &#x000b1; 1.66</td><td valign="top" align="left" rowspan="1" colspan="1">15.45 &#x000b1; 1.36</td><td valign="top" align="left" rowspan="1" colspan="1">15.54 &#x000b1; 1.12</td><td valign="top" align="left" rowspan="1" colspan="1">16.45 &#x000b1; 0.82</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uveitis</td><td valign="top" align="left" rowspan="1" colspan="1">17.00 &#x000b1; 1.00</td><td valign="top" align="left" rowspan="1" colspan="1">11.34 &#x000b1; 1.14</td><td valign="top" align="left" rowspan="1" colspan="1">15.33 &#x000b1; 1.15</td><td valign="top" align="left" rowspan="1" colspan="1">17.66 &#x000b1; 1.52</td><td valign="top" align="left" rowspan="1" colspan="1">15.66 &#x000b1; 2.08</td><td valign="top" align="left" rowspan="1" colspan="1">15.33 &#x000b1; 1.52</td><td valign="top" align="left" rowspan="1" colspan="1">15.33 &#x000b1; 1.53</td><td valign="top" align="left" rowspan="1" colspan="1">15.67 &#x000b1; 1.76</td></tr></tbody></table><table-wrap-foot><fn id="tfn13-opth-3-671"><p><bold>Note:</bold></p></fn><fn id="tfn3-opth-3-671"><label>*</label><p>Values in mmHg.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-opth-3-671" position="float"><label>Table 5</label><caption><p>Comfort and conjunctival hyperemia in the patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="2" colspan="1"/><th valign="top" align="left" rowspan="2" colspan="1"><bold>Group</bold></th><th valign="top" align="left" colspan="3" rowspan="1"><bold>Foreign body sensation</bold><hr/></th><th valign="top" align="left" colspan="3" rowspan="1"><bold>Conjunctival hyperemia</bold><hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>None/mild</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Moderate</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Severe</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>None/mild</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Moderate</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Severe</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">24 hours</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">144/486</td><td valign="top" align="left" rowspan="1" colspan="1">372/486</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">240/486</td><td valign="top" align="left" rowspan="1" colspan="1">180/486</td><td valign="top" align="left" rowspan="1" colspan="1">66/486</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">6/501</td><td valign="top" align="left" rowspan="1" colspan="1">141/501</td><td valign="top" align="left" rowspan="1" colspan="1">354/501</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">81/501</td><td valign="top" align="left" rowspan="1" colspan="1">420/501</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">7 days</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">423/486</td><td valign="top" align="left" rowspan="1" colspan="1">63/486</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">426/486</td><td valign="top" align="left" rowspan="1" colspan="1">60/486</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">126/501</td><td valign="top" align="left" rowspan="1" colspan="1">219/501</td><td valign="top" align="left" rowspan="1" colspan="1">126/501</td><td valign="top" align="left" rowspan="1" colspan="1">33/501</td><td valign="top" align="left" rowspan="1" colspan="1">252/501</td><td valign="top" align="left" rowspan="1" colspan="1">216/501</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">15 days</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">486/486</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">486/486</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">33/501</td><td valign="top" align="left" rowspan="1" colspan="1">123/501</td><td valign="top" align="left" rowspan="1" colspan="1">45/501</td><td valign="top" align="left" rowspan="1" colspan="1">330/501</td><td valign="top" align="left" rowspan="1" colspan="1">126/501</td><td valign="top" align="left" rowspan="1" colspan="1">45/501</td></tr></tbody></table></table-wrap></floats-group></article>